Ratings by Citizens (Liisa Bayko)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2021 | Arbutus Biopharma | ABUS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/9/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/27/2020 | Enanta Pharmaceuticals | ENTA | Upgrade | Market Outperform (Market Perform) |
48.82 (15.11) |
-69.05% | Details | |
| 7/27/2020 | Arbutus Biopharma | ABUS | New Coverage | Market Outperform (N/A) |
6.20 (4.87) |
-21.45% | Details | |
| 3/18/2020 | Aimmune Therapeutics | AIMT | Downgrade | Market Perform (Market Outperform) |
11.48 (34.49) |
200.44% | Details | |
| 2/5/2020 | Arbutus Biopharma | ABUS | Upgrade | Market Outperform (Market Perform) |
2.59 (4.87) |
88.03% | Details | |
| 2/3/2020 | Insmed | INSM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/3/2020 | Aimmune Therapeutics | AIMT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/22/2020 | Concert Pharmaceuticals | CNCE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/13/2019 | Sarepta Therapeutics | SRPT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/22/2019 | Enanta Pharmaceuticals | ENTA | Downgrade | Market Perform (Market Outperform) |
61.85 (15.11) |
-75.57% | Details | |
| 11/7/2019 | Achillion Pharmaceuticals | ACHN | Downgrade | Market Perform (Market Outperform) |
6.31 (0.79) |
-87.48% | Details | |
| 10/3/2019 | Heron Therapeutics | HRTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/14/2019 | Kiniksa | KNSA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Achillion Pharmaceuticals | ACHN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/13/2019 | Savara | SVRA | Downgrade | Market Perform (Market Outperform) |
10.50 (6.22) |
-40.76% | Details | |
| 4/2/2019 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/15/2019 | Insmed | INSM | Upgrade | Market Outperform (Market Perform) |
26.02 (111.60) |
328.9% | Details | |
| 1/30/2019 | Intercept Pharmaceuticals | ICPT | Upgrade | Market Outperform (Market Perform) |
115.82 (19.00) |
-83.6% | Details | |
| 10/9/2018 | Arbutus Biopharma | ABUS | Downgrade | Market Perform (Market Outperform) |
9.09 (2.59) |
-71.51% | Details | |
| 9/17/2018 | Kiniksa | KNSA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/5/2018 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details |
